Literature DB >> 6112655

The glucoregulatory response to intravenous glucose infusion in normal man: roles of insulin and glucose.

L Saccà, D Vitale, M Cicala, B Trimarco, B Ungaro.   

Abstract

In order to differentiate the roles of hyperinsulinemia and hyperglycemia per se in the homeostatic response to i.v. glucose administration, two groups of normal subjects were given either glucose alone (3.5 mg kg-1 min-1) or glucose (3 mg kg-1 min-1) in conjunction with somatostatin (500 microgram hr-1), insulin (0.15 mU kg-1 min-1) and glucagon (1 ng kg-1 min-1). Glucose kinetics were measured by the primed-constant infusion of 3-3H-glucose. During the infusion of glucose alone, plasma glucose stabilized at levels 45--50 mg/dl above the fasting values. Endogenous glucose output was markedly suppressed by 85%--90% while glucose uptake rose to values very close to the infusion rate of exogenous glucose. Glucose clearance remained unchanged. Plasma insulin rose to three-fourfold while plasma glucagon fell by 25%--30%. When glucose was infused with somatostatin, insulin, and glucagon, plasma insulin was maintained at levels 50% above baseline while glucagon remained at preinfusion levels. Under these conditions, the infusion of exogenous glucose resulted in a progressive increase of plasma glucose which did not stabilize until the end of the study period (190 mg/dl at 120 min). Endogenous glucose production was consistently suppressed (52%) but significantly less than observed with the infusion of glucose alone (p less than 0.01). Glucose uptake increased to the same extent as with glucose alone, despite the more pronounced hyperglycemia. Thus, glucose clearance fell significantly below baseline (25%--30%; p less than 0.01). These data demonstrate that hyperglycemia per se (fixed, near basal levels of insulin and glucagon) certainly contributes to the glucoregulatory response to i.v. glucose administration by both inhibiting endogenous glucose output and increasing tissue glucose uptake. However, the extra-insulin evoked by hyperglycemia is necessary for the glucoregulatory system to respond to the glucose load with maximal effectiveness.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112655     DOI: 10.1016/0026-0495(81)90180-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo.

Authors:  S R Myers; D W Biggers; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  Blood lactate behavior after glucose load in diabetes mellitus.

Authors:  R Prando; V Cheli; P Buzzo; P Melga; E Ansaldi; S Accoto
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

3.  Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

Authors:  L Saccà; M Cicala; B Trimarco; B Ungaro; C Vigorito
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

4.  Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns.

Authors:  D E Hertz; C A Karn; Y M Liu; E A Liechty; S C Denne
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Mechanisms of epinephrine-induced glucose intolerance in normal humans.

Authors:  L Saccà; C Vigorito; M Cicala; B Ungaro; R S Sherwin
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Mechanisms of insulin resistance following injury.

Authors:  P R Black; D C Brooks; P Q Bessey; R R Wolfe; D W Wilmore
Journal:  Ann Surg       Date:  1982-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.